USPTO serial 79225437
MYVAC
Reviewed by CopyMark Law Group
Reg. 5543202Status 706Registered
- Filing date
- Status date
- Registration date
- Aug 21, 2018
- Examiner
- SULLIVAN, JOHN C
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with MYVAC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ILLKIRCH GRAFFENSTADEN, FR
ILLKIRCH GRAFFENSTADEN, FR
ILLKIRCH GRAFFENSTADEN, FR
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Pina Campagna
Pina Campagna Carter, DeLuca, and Farrell, LLP576 Broad Hollow Rd.Melville, NY 11747United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Therapeutic vaccines in oncology; customized immunotherapy products, namely, pharmaceutical preparations for immunotherapy; therapeutic vaccine preparations in oncology for human use | ACTIVE | — |
| 042 | [ Design and development of medical diagnostic apparatus in the field of oncology; ] research and development in the field of diagnostic preparations for cancer patients; [ biological research and analysis services; ] medical research services provided by medical analysis laboratories in the field of oncology; [ human tissue analysis for medical research; analysis of human blood and serum for medical research; medical laboratory services, namely, preparation of immunohistological samples to be analyzed in research laboratories; ] research and development of vaccines and medicines in the field of oncology | ACTIVE | — |
| 044 | [ Medical analysis, namely, human tissue analysis services for medical treatments; ] medical analysis services for cancer diagnosis and prognosis [ ; medical analysis services in the nature of analysis of samples taken from patients ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by TRANSGENE SA
- Other trademarks owned by TRANSGENE SA
- Other trademarks owned by TRANSGENE SA
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MYVAC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 21, 2026 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 14, 2026 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 14, 2026 | INPC | INVALIDATION PROCESSED | — |
| Oct 10, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Feb 10, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 10, 2025 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Feb 10, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 19, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 21, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Dec 28, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 6, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 5, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 21, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 21, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 5, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 5, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 2, 2018 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| May 16, 2018 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 16, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 16, 2018 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 3, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 1, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 30, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 30, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 30, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 8, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 15, 2018 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 15, 2018 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 10, 2018 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 9, 2018 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 2, 2018 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 29, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 25, 2018 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |